Two Delhi CGHS Doctors Suspended For Favouring Pharma Company

NEW DELHI : Two central government health scheme (CGHS) doctors have been suspended and few others may face disciplinary action for allegedly prescribing certain medicines to favour a particular pharmaceutical company.

According to official sources, the two chief medical officers – one posted at the CGHS dispensary in Shahdara and other one at Dwarka Sector 9 – were prescribing the drugs even though the same medicines were available at the CGHS central warehouse at affordable rates.

The action against the doctors comes after Union health minister Mansukh Mandaviya’s office received a complaint in this connection a couple of months ago.

The minister ordered an enquiry and the preliminary probe revealed severe violations in prescribing medicines and that a group of doctors were favouring a particular pharmaceutical company, an official source said on Sunday.

  • Related Posts

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory